These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 33790553)

  • 1. Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy.
    Sun S; Ding Z; Yang X; Zhao X; Zhao M; Gao L; Chen Q; Xie S; Liu A; Yin S; Xu Z; Lu X
    Int J Nanomedicine; 2021; 16():2337-2356. PubMed ID: 33790553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanobodies in cancer.
    Verhaar ER; Woodham AW; Ploegh HL
    Semin Immunol; 2021 Feb; 52():101425. PubMed ID: 33272897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanobody-based cancer therapy of solid tumors.
    Kijanka M; Dorresteijn B; Oliveira S; van Bergen en Henegouwen PM
    Nanomedicine (Lond); 2015 Jan; 10(1):161-74. PubMed ID: 25597775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanobodies as Versatile Tools to Understand, Diagnose, Visualize and Treat Cancer.
    Van Audenhove I; Gettemans J
    EBioMedicine; 2016 Jun; 8():40-48. PubMed ID: 27428417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment.
    Wang J; Kang G; Yuan H; Cao X; Huang H; de Marco A
    Front Immunol; 2021; 12():838082. PubMed ID: 35116045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanobody-A versatile tool for cancer diagnosis and therapeutics.
    Liu M; Li L; Jin D; Liu Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1697. PubMed ID: 33470555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanobody Conjugates for Targeted Cancer Therapy and Imaging.
    Kang W; Ding C; Zheng D; Ma X; Yi L; Tong X; Wu C; Xue C; Yu Y; Zhou Q
    Technol Cancer Res Treat; 2021; 20():15330338211010117. PubMed ID: 33929911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanobodies in cell-mediated immunotherapy: On the road to fight cancer.
    Maali A; Gholizadeh M; Feghhi-Najafabadi S; Noei A; Seyed-Motahari SS; Mansoori S; Sharifzadeh Z
    Front Immunol; 2023; 14():1012841. PubMed ID: 36761751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiolabeled nanobodies for tumor targeting: From bioengineering to imaging and therapy.
    Piramoon M; Khodadust F; Hosseinimehr SJ
    Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188529. PubMed ID: 33647388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
    Bannas P; Hambach J; Koch-Nolte F
    Front Immunol; 2017; 8():1603. PubMed ID: 29213270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application Progress of the Single Domain Antibody in Medicine.
    Tang H; Gao Y; Han J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NanoBERTa-ASP: predicting nanobody paratope based on a pretrained RoBERTa model.
    Li S; Meng X; Li R; Huang B; Wang X
    BMC Bioinformatics; 2024 Mar; 25(1):122. PubMed ID: 38515052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Therapeutic Potential of Nanobodies.
    Jovčevska I; Muyldermans S
    BioDrugs; 2020 Feb; 34(1):11-26. PubMed ID: 31686399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Domain Antibodies or Nanobodies: A Class of Next-Generation Antibodies.
    Khodabakhsh F; Behdani M; Rami A; Kazemi-Lomedasht F
    Int Rev Immunol; 2018; 37(6):316-322. PubMed ID: 30741045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanobodies as versatile tools: A focus on targeted tumor therapy, tumor imaging and diagnostics.
    Al-Baradie RS
    Hum Antibodies; 2020; 28(4):259-272. PubMed ID: 32831197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanobodies in Human Infections: Prevention, Detection, and Treatment.
    Sanaei M; Setayesh N; Sepehrizadeh Z; Mahdavi M; Yazdi MH
    Immunol Invest; 2020 Nov; 49(8):875-896. PubMed ID: 31856615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging applications of nanobodies in cancer therapy.
    Awad RM; Meeus F; Ceuppens H; Ertveldt T; Hanssens H; Lecocq Q; Mateusiak L; Zeven K; Valenta H; De Groof TWM; De Vlaeminck Y; Krasniqi A; De Veirman K; Goyvaerts C; D'Huyvetter M; Hernot S; Devoogdt N; Breckpot K
    Int Rev Cell Mol Biol; 2022; 369():143-199. PubMed ID: 35777863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotoxins and nanobody-based immunotoxins: review and update.
    Khirehgesh MR; Sharifi J; Safari F; Akbari B
    J Drug Target; 2021 Sep; 29(8):848-862. PubMed ID: 33615933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status and future expectations of nanobodies in oncology trials.
    De Pauw T; De Mey L; Debacker JM; Raes G; Van Ginderachter JA; De Groof TWM; Devoogdt N
    Expert Opin Investig Drugs; 2023; 32(8):705-721. PubMed ID: 37638538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of Nanobodies.
    Muyldermans S
    Annu Rev Anim Biosci; 2021 Feb; 9():401-421. PubMed ID: 33233943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.